NASDAQ:SWAV - Shockwave Medical Stock Price, Forecast & News

Shockwave Medical's stock was trading at $34.44 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SWAV stock has decreased by 5.0% and is now trading at $32.72. View which stocks have been mosted impacted by Coronavirus.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Shockwave Medical in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Shockwave Medical.

Shockwave Medical is scheduled to release its next quarterly earnings announcement on Wednesday, May 13th 2020. View our earnings forecast for Shockwave Medical.

Shockwave Medical Inc (NASDAQ:SWAV) announced its quarterly earnings data on Thursday, February, 13th. The company reported ($0.49) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.51) by $0.02. The company earned $14.31 million during the quarter, compared to analyst estimates of $13.34 million. Shockwave Medical had a negative net margin of 119.06% and a negative return on equity of 37.20%. View Shockwave Medical's earnings history.

Shockwave Medical issued an update on its FY 2020 After-Hours earnings guidance on Thursday, February, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $74-77 million, compared to the consensus revenue estimate of $75.34 million.

7 brokerages have issued 1-year target prices for Shockwave Medical's stock. Their forecasts range from $40.00 to $54.00. On average, they anticipate Shockwave Medical's stock price to reach $48.00 in the next twelve months. This suggests a possible upside of 46.7% from the stock's current price. View analysts' price targets for Shockwave Medical.

News headlines about SWAV stock have been trending positive this week, according to InfoTrie Sentiment. The research firm identifies negative and positive media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Shockwave Medical earned a media sentiment score of 2.1 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the immediate future. View the latest news aboutShockwave Medical.

Shockwave Medical saw a increase in short interest in March. As of March 13th, there was short interest totaling 3,945,400 shares, an increase of 5.5% from the February 27th total of 3,740,000 shares. Based on an average daily volume of 560,600 shares, the short-interest ratio is presently 7.0 days. Approximately 20.2% of the company's shares are short sold. View Shockwave Medical's Current Options Chain.

Some companies that are related to Shockwave Medical include Globus Medical (GMED), Tandem Diabetes Care (TNDM), ICU Medical (ICUI), Integra Lifesciences (IART), Nevro (NVRO), NuVasive (NUVA), Irhythm Technologies (IRTC), Merit Medical Systems (MMSI), Glaukos (GKOS), Cantel Medical (CMD), Inspire Medical Systems (INSP), Luminex (LMNX), Cardiovascular Systems (CSII), AtriCure (ATRC) and Atrion (ATRI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Shockwave Medical investors own include NVIDIA (NVDA), Alibaba Group (BABA), salesforce.com (CRM), Walt Disney (DIS), Paypal (PYPL), Twilio (TWLO), Trade Desk (TTD), Roku (ROKU), Home Depot (HD) and Veeva Systems (VEEV).

(SWAV) raised $75 million in an initial public offering on Thursday, March 7th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

Shockwave Medical trades on the NASDAQ under the ticker symbol "SWAV."

Shockwave Medical's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include FMR LLC (16.49%), Alpine Global Management LLC (2.56%), Capital World Investors (2.07%), Jennison Associates LLC (2.05%), State Street Corp (1.53%) and Lord Abbett & CO. LLC (1.42%). Company insiders that own Shockwave Medical stock include Antoine Papiernik, Dan Puckett, Douglas Evan Godshall, Frederic H Moll, Isaac Zacharias, James E Flynn and Sofinnova Capital Vii Fcpr. View institutional ownership trends for Shockwave Medical.

SWAV stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG, Alyeska Investment Group L.P., Goldman Sachs Group Inc., Cubist Systematic Strategies LLC, and NumerixS Investment Technologies Inc. Company insiders that have sold Shockwave Medical company stock in the last year include Antoine Papiernik, Dan Puckett, Douglas Evan Godshall, Frederic H Moll, Isaac Zacharias, and Sofinnova Capital Vii Fcpr. View insider buying and selling activity for Shockwave Medical.

SWAV stock was bought by a variety of institutional investors in the last quarter, including Alpine Global Management LLC, FMR LLC, Capital World Investors, State Street Corp, Jennison Associates LLC, Lord Abbett & CO. LLC, Point72 Asset Management L.P., and Geode Capital Management LLC. View insider buying and selling activity for Shockwave Medical.

Shares of SWAV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of SWAV stock can currently be purchased for approximately $32.72.

Shockwave Medical has a market capitalization of $1.04 billion and generates $42.93 million in revenue each year. The company earns $-51,110,000.00 in net income (profit) each year or ($2.14) on an earnings per share basis. Shockwave Medical employs 162 workers across the globe. View additional information about Shockwave Medical.

The official website for Shockwave Medical is http://www.shockwavemedical.com/.

Shockwave Medical's mailing address is 5403 Betsy Ross Drive, Santa Clara CA, 95054. The company can be reached via phone at 510-279-4262 or via email at [email protected]